{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T08:01:58Z","timestamp":1784880118560,"version":"3.55.0"},"posted":{"date-parts":[[2026,2,12]]},"group-title":"In Review","reference-count":54,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,1,29]]},"abstract":"<title>Abstract<\/title>\n                <p>\n                  Rapid-acting antidepressants like ketamine and serotonergic psychedelics show promise for treatment-resistant depression (TRD), but the molecular mechanisms that contribute to their therapeutic effects remain unclear. Induced pluripotent stem cells (iPSCs) offer a platform to model human cortical neurons and investigate drug effects in a human-relevant system. Here, iPSCs from individuals with TRD and healthy volunteers (HVs) were differentiated into mature cortical-like neurons and treated for six and 24 hours with agents being investigated as rapid-acting antidepressants, including (2\n                  <italic>R<\/italic>\n                  ,6\n                  <italic>R<\/italic>\n                  )-hydroxynorketamine (HNK), psilocybin, lysergic acid diethylamide (LSD), and 2,5-Dimethoxy-4-iodoamphetamine (DOI). Bulk and single-cell RNA sequencing assessed global and cell-type-specific transcriptomic responses. Synaptic proteins were evaluated via Western blotting and immunocytochemistry. To validate translational relevance, transcriptomic results were compared to CSF proteomics from ketamine-treated HVs.\nDespite differing initial pharmacological targets, overall gene expression across all compounds was highly correlated at matched timepoints compared to vehicle control, suggesting shared downstream effects. Both glutamatergic and serotonergic drugs converged on pathways involving inflammation, mTORC1 signaling, and cellular growth. At the single-cell level, HNK showed distinct cell-type specific alterations: upregulation in excitatory neurons and concomitant downregulation of inhibitory neuron populations. Differentially expressed genes from HNK-treated neurons also overlapped with CSF proteomic signatures from ketamine-treated individuals, supporting the model\u2019s translational relevance. This study is the first to assess multiple putative rapid-acting antidepressants in parallel using an iPSC-derived neuron model. Both convergent and drug-specific changes in gene expression and pathway enrichment were observed across diverse compounds, supporting the use of human iPSC-derived neurons in antidepressant drug discovery.\n                  <bold>Clinical Trial Registry<\/bold>\n                  : www.clinical trials.gov, NCT02484456\n                <\/p>","DOI":"10.21203\/rs.3.rs-8733841\/v1","type":"posted-content","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T17:35:46Z","timestamp":1770917746000},"source":"Crossref","is-referenced-by-count":0,"title":["Time-Dependent Effects of Rapid-Acting Antidepressants in iPSC-Derived Neurons from Treatment-Resistant Depression and Healthy Volunteers"],"prefix":"10.21203","author":[{"given":"Jenessa","family":"Johnston","sequence":"first","affiliation":[{"name":"NIMH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyong","family":"Peng","sequence":"additional","affiliation":[{"name":"National Institute of Mental Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peixiong","family":"Yuan","sequence":"additional","affiliation":[{"name":"NIH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mani","family":"Yavi","sequence":"additional","affiliation":[{"name":"National Institute of Mental Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3809-9451","authenticated-orcid":false,"given":"Bashkim","family":"Kadriu","sequence":"additional","affiliation":[{"name":"NIMH-NIH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioline","family":"Henter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandi","family":"Quintanilla","sequence":"additional","affiliation":[{"name":"University of Texas Health Science Center at Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdel G.","family":"Elkahloun","sequence":"additional","affiliation":[{"name":"National Human Genome Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruin","family":"Moaddel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6323-4969","authenticated-orcid":false,"given":"Anton","family":"Schulmann","sequence":"additional","affiliation":[{"name":"National Institute of Mental Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirmala","family":"Akula","sequence":"additional","affiliation":[{"name":"National Institutes of Mental Health, NIH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1093-1648","authenticated-orcid":false,"given":"Mark","family":"Kvarta","sequence":"additional","affiliation":[{"name":"National Institute of Mental Health\/NIH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9469-305X","authenticated-orcid":false,"given":"Francis","family":"McMahon","sequence":"additional","affiliation":[{"name":"National Institute of Mental Health Intramural Research Program; National Institutes of Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Zarate","sequence":"additional","affiliation":[{"name":"NIMH"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"11","key":"ref1","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1176\/ps.2009.60.11.1439","article-title":"What did STAR* D teach us? Results from a large-scale, practical, clinical trial for patients with depression","volume":"60","author":"Gaynes BN","year":"2009","unstructured":"Gaynes BN, Warden D, Trivedi MH, Wisniewski SR, Fava M, Rush AJ. What did STAR* D teach us? Results from a large-scale, practical, clinical trial for patients with depression. Psychiatr Serv 2009; 60(11): 1439\u20131445.","journal-title":"Psychiatr Serv"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/515200a","article-title":"The best way forward","volume":"515","author":"Monteggia LM","year":"2014","unstructured":"Monteggia LM, Malenka RC, Deisseroth K. The best way forward. Nature 2014; 515: 200\u2013201.","journal-title":"Nature"},{"issue":"9","key":"ref3","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/mp.2017.40","article-title":"Pluripotent stem cells in neuropsychiatric disorders","volume":"22","author":"Soliman MA","year":"2017","unstructured":"Soliman MA, Aboharb F, Zeltner N, Studer L. Pluripotent stem cells in neuropsychiatric disorders. Mol Psychiatry 2017; 22(9): 1241\u20131249.","journal-title":"Mol Psychiatry"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1007\/s00702-020-02197-9","article-title":"Mental health dished up\u2014the use of iPSC models in neuropsychiatric research","volume":"127","author":"McNeill RV","year":"2020","unstructured":"McNeill RV, Ziegler GC, Radtke F, Nieberler M, Lesch K-P, Kittel-Schneider S. Mental health dished up\u2014the use of iPSC models in neuropsychiatric research. J Neural Transm (Vienna) 2020; 127: 1547\u20131568.","journal-title":"J Neural Transm (Vienna)"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13073-017-0512-3","article-title":"Modeling psychiatric disorders using patient stem cell-derived neurons: a way forward","volume":"10","author":"Vadodaria KC","year":"2018","unstructured":"Vadodaria KC, Amatya DN, Marchetto MC, Gage FH. Modeling psychiatric disorders using patient stem cell-derived neurons: a way forward. Genome Med 2018; 10: 1.","journal-title":"Genome Med"},{"issue":"6","key":"ref6","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/s41380-019-0363-y","article-title":"Serotonin-induced hyperactivity in SSRI-resistant major depressive disorder patient-derived neurons","volume":"24","author":"Vadodaria KC","year":"2019","unstructured":"Vadodaria KC, Ji Y, Skime M, Paquola A, Nelson T, Hall-Flavin D et al. Serotonin-induced hyperactivity in SSRI-resistant major depressive disorder patient-derived neurons. Mol Psychiatry 2019; 24(6): 795\u2013807.","journal-title":"Mol Psychiatry"},{"issue":"6","key":"ref7","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/s41380-019-0377-5","article-title":"Altered serotonergic circuitry in SSRI-resistant major depressive disorder patient-derived neurons","volume":"24","author":"Vadodaria KC","year":"2019","unstructured":"Vadodaria KC, Ji Y, Skime M, Paquola AC, Nelson T, Hall-Flavin D et al. Altered serotonergic circuitry in SSRI-resistant major depressive disorder patient-derived neurons. Mol Psychiatry 2019; 24(6): 808\u2013818.","journal-title":"Mol Psychiatry"},{"issue":"8","key":"ref8","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate CA","year":"2006","unstructured":"Zarate CA, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 2006; 63(8): 856\u2013864.","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"ref9","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/mp.2017.255","article-title":"Mechanisms of ketamine action as an antidepressant","volume":"23","author":"Zanos P","year":"2018","unstructured":"Zanos P, Gould TD. Mechanisms of ketamine action as an antidepressant. Mol Psychiatry 2018; 23(4): 801\u2013811.","journal-title":"Mol Psychiatry"},{"issue":"7604","key":"ref10","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature17998","article-title":"NMDAR inhibition-independent antidepressant actions of ketamine metabolites","volume":"533","author":"Zanos P","year":"2016","unstructured":"Zanos P, Moaddel R, Morris PJ, Georgiou P, Fischell J, Elmer GI et al. NMDAR inhibition-independent antidepressant actions of ketamine metabolites. Nature 2016; 533(7604): 481\u2013486.","journal-title":"Nature"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/mp.2017.241","article-title":"Ketamine enhances structural plasticity in mouse mesencephalic and human iPSC-derived dopaminergic neurons via AMPAR-driven BDNF and mTOR signaling","volume":"23","author":"Cavalleri L","year":"2018","unstructured":"Cavalleri L, Merlo Pich E, Millan MJ, Chiamulera C, Kunath T, Spano PF et al. Ketamine enhances structural plasticity in mouse mesencephalic and human iPSC-derived dopaminergic neurons via AMPAR-driven BDNF and mTOR signaling. Mol Psychiatry 2018; 23(4): 812\u2013823.","journal-title":"Mol Psychiatry"},{"issue":"10","key":"ref12","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.3390\/cells8101139","article-title":"Ketamine increases proliferation of human iPSC-derived neuronal progenitor cells via insulin-like growth factor 2 and independent of the NMDA receptor","volume":"8","author":"Grossert A","year":"2019","unstructured":"Grossert A, Mehrjardi NZ, Bailey SJ, Lindsay MA, Hescheler J, \u0160ari\u0107 T et al. Ketamine increases proliferation of human iPSC-derived neuronal progenitor cells via insulin-like growth factor 2 and independent of the NMDA receptor. Cells 2019; 8(10): 1139.","journal-title":"Cells"},{"issue":"7","key":"ref13","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S2215-0366(16)30065-7","article-title":"Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study","volume":"3","author":"Carhart-Harris RL","year":"2016","unstructured":"Carhart-Harris RL, Bolstridge M, Rucker J, Day CMJ, Erritzoe D, Kaelen M et al. Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. Lancet Psychiatry 2016; 3(7): 619\u2013627.","journal-title":"Lancet Psychiatry"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMoa2206443","article-title":"Single-dose psilocybin for a treatment-resistant episode of major depression","volume":"387","author":"Goodwin GM","year":"2022","unstructured":"Goodwin GM, Aaronson ST, Alvarez O, Arden PC, Baker A, Bennett JC et al. Single-dose psilocybin for a treatment-resistant episode of major depression. N Engl J Med 2022; 387: 1637\u20131648.","journal-title":"N Engl J Med"},{"issue":"11","key":"ref15","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1016\/j.celrep.2018.05.022","article-title":"Psychedelics promote structural and functional neural plasticity","volume":"23","author":"Ly C","year":"2018","unstructured":"Ly C, Greb AC, Cameron LP, Wong JM, Barragan EV, Wilson PC et al. Psychedelics promote structural and functional neural plasticity. Cell Rep 2018; 23(11): 3170\u20133182.","journal-title":"Cell Rep"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1076459","DOI":"10.3389\/fpsyt.2022.1076459","article-title":"Serotonergic psychedelics for depression: What do we know about neurobiological mechanisms of action?","volume":"13","author":"Husain MI","year":"2023","unstructured":"Husain MI, Ledwos N, Fellows E, Baer J, Rosenblat JD, Blumberger DM et al. Serotonergic psychedelics for depression: What do we know about neurobiological mechanisms of action? Front Psychiatry 2023; 13: 1076459.","journal-title":"Front Psychiatry"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/ijnp\/pyaa087","article-title":"Ketamine and serotonergic psychedelics: Common mechanisms underlying the effects of rapid-acting antidepressants","volume":"24","author":"Kadriu B","year":"2021","unstructured":"Kadriu B, Greenwald M, Henter ID, Gilbert JR, Kraus C, Park LT et al. Ketamine and serotonergic psychedelics: Common mechanisms underlying the effects of rapid-acting antidepressants Int J Neuropsychopharmacol 2021; 24(1): 8\u201321.","journal-title":"Int J Neuropsychopharmacol"},{"issue":"20","key":"ref18","doi-asserted-by":"crossref","first-page":"E2725-E2734","DOI":"10.1073\/pnas.1504393112","article-title":"Neuronal medium that supports basic synaptic functions and activity of human neurons in vitro","volume":"112","author":"Bardy C","year":"2015","unstructured":"Bardy C, Van Den Hurk M, Eames T, Marchand C, Hernandez RV, Kellogg M et al. Neuronal medium that supports basic synaptic functions and activity of human neurons in vitro. Proc Natl Acad Sci USA 2015; 112(20): E2725-E2734.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1186\/s12859-016-1323-z","article-title":"variancePartition: interpreting drivers of variation in complex gene expression studies","volume":"17","author":"Hoffman GE","year":"2016","unstructured":"Hoffman GE, Schadt EE, Hoffman GE, Schadt EE. variancePartition: interpreting drivers of variation in complex gene expression studies. BMC Bioinformatics 2016; 17(1): 483.","journal-title":"BMC Bioinformatics"},{"issue":"2","key":"ref20","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/bioinformatics\/btaa687","article-title":"Dream: powerful differential expression analysis for repeated measures designs","volume":"37","author":"Hoffman GE","year":"2021","unstructured":"Hoffman GE, Roussos P. Dream: powerful differential expression analysis for repeated measures designs. Bioinformatics 2021; 37(2): 192\u2013201.","journal-title":"Bioinformatics"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"14049","DOI":"10.1038\/ncomms14049","article-title":"Massively parallel digital transcriptional profiling of single cells","volume":"8","author":"Zheng GXY","year":"2017","unstructured":"Zheng GXY, Terry JM, Belgrader P, Ryvkin P, Bent ZW, Wilson R et al. Massively parallel digital transcriptional profiling of single cells. Nat Commun 2017; 8(1): 14049.","journal-title":"Nat Commun"},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","article-title":"Dictionary learning for integrative, multimodal and scalable single-cell analysis","volume":"42","author":"Hao Y","year":"2024","unstructured":"Hao Y, Stuart T, Kowalski MH, Choudhary S, Hoffman P, Hartman A et al. Dictionary learning for integrative, multimodal and scalable single-cell analysis. Nat Biotechnol 2024; 42(2): 293\u2013304.","journal-title":"Nat Biotechnol"},{"issue":"8","key":"ref23","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/s41576-023-00586-w","article-title":"Best practices for single-cell analysis across modalities","volume":"24","author":"Heumos L","year":"2023","unstructured":"Heumos L, Schaar AC, Lance C, Litinetskaya A, Drost F, Zappia L et al. Best practices for single-cell analysis across modalities. Nat Rev Genet 2023; 24(8): 550\u2013572.","journal-title":"Nat Rev Genet"},{"issue":"12","key":"ref24","doi-asserted-by":"crossref","first-page":"108527","DOI":"10.1016\/j.isci.2023.108527","article-title":"Cerebrospinal fluid exploratory proteomics and ketamine metabolite pharmacokinetics in human volunteers after ketamine infusion","volume":"26","author":"Moaddel R","year":"2023","unstructured":"Moaddel R, Farmer CA, Yavi M, Kadriu B, Zhu M, Fan J et al. Cerebrospinal fluid exploratory proteomics and ketamine metabolite pharmacokinetics in human volunteers after ketamine infusion. iScience 2023; 26(12): 108527.","journal-title":"iScience"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1016\/j.stemcr.2022.07.012","article-title":"Development of a platform to investigate long-term potentiation in human iPSC-derived neuronal networks","volume":"17","author":"Pr\u00e9 D","year":"2022","unstructured":"Pr\u00e9 D, Wooten AT, Biesmans S, Hinckley S, Zhou H, Sherman SP et al. Development of a platform to investigate long-term potentiation in human iPSC-derived neuronal networks. Stem Cell Reports 2022; 17: 2141\u20132155.","journal-title":"Stem Cell Reports"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","first-page":"26181","DOI":"10.1038\/srep26181","article-title":"Physiological maturation and drug responses of human induced pluripotent stem cell-derived cortical neuronal networks in long-term culture","volume":"6","author":"Odawara A","year":"2016","unstructured":"Odawara A, Katoh H, Matsuda N, Suzuki I. Physiological maturation and drug responses of human induced pluripotent stem cell-derived cortical neuronal networks in long-term culture. Sci Rep 2016; 6(1): 26181.","journal-title":"Sci Rep"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1101\/308486","author":"Kim ES","year":"2018","unstructured":"Kim ES, Leonardo ED, Dranovsky A. iPSC-derived neurons as a tool for probing molecular pharmacology of antipsychotic action. bioRxiv 2018; doi: https:\/\/doi.org\/10.1101\/308486."},{"issue":"7","key":"ref28","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1038\/s41380-018-0028-2","article-title":"Ketamine has distinct electrophysiological and behavioral effects in depressed and healthy subjects","volume":"24","author":"Nugent AC","year":"2019","unstructured":"Nugent AC, Ballard ED, Gould TD, Park LT, Moaddel R, Brutsche NE et al. Ketamine has distinct electrophysiological and behavioral effects in depressed and healthy subjects. Mol Psychiatry 2019; 24(7): 1040\u20131052.","journal-title":"Mol Psychiatry"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"108573","DOI":"10.1016\/j.neuropharm.2021.108573","article-title":"The role of the excitation:inhibition functional balance in the mPFC in the onset of antidepressants","volume":"191","author":"Yin Y-Y","year":"2021","unstructured":"Yin Y-Y, Wang Y-H, Liu W-G, Yao J-Q, Yuan J, Li Z-H et al. The role of the excitation:inhibition functional balance in the mPFC in the onset of antidepressants. Neuropharmacology 2021; 191: 108573.","journal-title":"Neuropharmacology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1523\/JNEUROSCI.1316-22.2022","article-title":"NMDA receptor activation-dependent antidepressant-relevant behavioral and synaptic actions of ketamine","volume":"43","author":"Zanos P","year":"2023","unstructured":"Zanos P, Brown KA, Georgiou P, Yuan P, Zarate CAJ, Thompson SM et al. NMDA receptor activation-dependent antidepressant-relevant behavioral and synaptic actions of ketamine. J Neurosci 2023; 43: 1038\u20131050.","journal-title":"J Neurosci"},{"issue":"11","key":"ref31","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.tips.2021.08.003","article-title":"Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics","volume":"42","author":"Aleksandrova LR","year":"2021","unstructured":"Aleksandrova LR, Phillips AG. Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics. Trends Pharmacol Sci 2021; 42(11): 929\u2013942.","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nri.2015.5","article-title":"The role of inflammation in depression: from evolutionary imperative to modern treatment target","volume":"16","author":"Miller AH","year":"2016","unstructured":"Miller AH, Raison CL. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol 2016; 16(1): 22\u201334.","journal-title":"Nat Rev Immunol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"109422","DOI":"10.1016\/j.neuropharm.2023.109422","article-title":"Ketamine and serotonergic psychedelics: An update on the mechanisms and biosignatures underlying rapid-acting antidepressant treatment","volume":"226","author":"Johnston JN","year":"2023","unstructured":"Johnston JN, Kadriu B, Allen J, Gilbert JR, Henter ID, Zarate CAJ. Ketamine and serotonergic psychedelics: An update on the mechanisms and biosignatures underlying rapid-acting antidepressant treatment. Neuropharmacology 2023; 226: 109422.","journal-title":"Neuropharmacology"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"155582","DOI":"10.1016\/j.cyto.2021.155582","article-title":"Role of IL-6 in the regulation of neuronal development, survival and function","volume":"144","author":"Kummer KK","year":"2021","unstructured":"Kummer KK, Zeidler M, Kalpachidou T, Kress M. Role of IL-6 in the regulation of neuronal development, survival and function. Cytokine 2021; 144: 155582.","journal-title":"Cytokine"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s10571-012-9891-6","article-title":"Neuroprotection of interleukin-6 against NMDA-induced neurotoxicity is mediated by JAK\/STAT3, MAPK\/ERK, and PI3K\/AKT signaling pathways","volume":"33","author":"Fang X-X","year":"2013","unstructured":"Fang X-X, Jiang X-L, Han X-H, Peng Y-P, Qiu Y-H. Neuroprotection of interleukin-6 against NMDA-induced neurotoxicity is mediated by JAK\/STAT3, MAPK\/ERK, and PI3K\/AKT signaling pathways. Cell Mol Neurobiol 2013; 33: 241\u2013251.","journal-title":"Cell Mol Neurobiol"},{"issue":"6","key":"ref36","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/s41386-020-0644-9","article-title":"Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin","volume":"45","author":"Abdallah CG","year":"2020","unstructured":"Abdallah CG, Averill LA, Gueorguieva R, Goktas S, Purohit P, Ranganathan M et al. Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin. Neuropsychopharmacology 2020; 45(6): 990\u2013997.","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"ref37","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/jnc.15540","article-title":"Molecular insights into psychedelic drug action","volume":"162","author":"Slocum ST","year":"2022","unstructured":"Slocum ST, DiBerto JF, Roth BL. Molecular insights into psychedelic drug action. J Neurochem 2022; 162(1): 24\u201338.","journal-title":"J Neurochem"},{"issue":"7","key":"ref38","doi-asserted-by":"crossref","first-page":"8219","DOI":"10.3390\/ijms13078219","article-title":"The neuroprotective functions of transforming growth factor beta proteins","volume":"13","author":"Dobolyi A","year":"2012","unstructured":"Dobolyi A, Vincze C, P\u00e1l G, Lovas G. The neuroprotective functions of transforming growth factor beta proteins. Int J Mol Sci 2012; 13(7): 8219\u20138258.","journal-title":"Int J Mol Sci"},{"issue":"39","key":"ref39","doi-asserted-by":"crossref","first-page":"9599","DOI":"10.1523\/JNEUROSCI.2589-08.2008","article-title":"Schwann cells promote synaptogenesis at the neuromuscular junction via transforming growth factor-beta1","volume":"28","author":"Feng Z","year":"2008","unstructured":"Feng Z, Ko CP. Schwann cells promote synaptogenesis at the neuromuscular junction via transforming growth factor-beta1. J Neurosci 2008; 28(39): 9599\u20139609.","journal-title":"J Neurosci"},{"issue":"1","key":"ref40","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/s41398-022-01943-9","article-title":"IGF-1 release in the medial prefrontal cortex mediates the rapid and sustained antidepressant-like actions of ketamine","volume":"12","author":"Deyama S","year":"2022","unstructured":"Deyama S, Kondo M, Shimada S, Kaneda K. IGF-1 release in the medial prefrontal cortex mediates the rapid and sustained antidepressant-like actions of ketamine. Transl Psychiatry 2022; 12(1): 178.","journal-title":"Transl Psychiatry"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pnpbp.2016.08.008","article-title":"Up-regulation of insulin-like growth factor 2 by ketamine requires glycogen synthase kinase-3 inhibition","volume":"72","author":"Grieco SF","year":"2016","unstructured":"Grieco SF, Cheng L, Eldar-Finkelman H, Jope RS, Beurel E. Up-regulation of insulin-like growth factor 2 by ketamine requires glycogen synthase kinase-3 inhibition. Prog Neuropsychopharmacol Biol Psychiatry 2016; 72: 49\u201354.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"100404","DOI":"10.1016\/j.ynstr.2021.100404","article-title":"Longitudinal CSF proteome profiling in mice to uncover the acute and sustained mechanisms of action of rapid acting antidepressant (2R,6R)-hydroxynorketamine (HNK)","volume":"15","author":"Herzog DP","year":"2021","unstructured":"Herzog DP, Perumal N, Manicam C, Treccani G, Nadig J, Rossmanith M et al. Longitudinal CSF proteome profiling in mice to uncover the acute and sustained mechanisms of action of rapid acting antidepressant (2R,6R)-hydroxynorketamine (HNK). Neurobiol Stress 2021; 15: 100404.","journal-title":"Neurobiol Stress"},{"issue":"1","key":"ref43","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1089\/psymed.2024.0002","article-title":"The antidepressant effects of vaporized N,N-Dimethyltryptamine: An open-label pilot trial in treatment-resistant depression","volume":"3","author":"Falchi-Carvalho M","year":"2025","unstructured":"Falchi-Carvalho M, Barros H, Bolcont R, Laborde S, Wie\u00dfner I, Silva SRB et al. The antidepressant effects of vaporized N,N-Dimethyltryptamine: An open-label pilot trial in treatment-resistant depression. Psychedelic Med (New Rochelle) 2025; 3(1): 48\u201352.","journal-title":"Psychedelic Med (New Rochelle)"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.euroneuro.2023.07.011","article-title":"Psilocybin-assisted therapy for depression: A systematic review and dose-response meta-analysis of human studies","volume":"76","author":"Perez N","year":"2023","unstructured":"Perez N, Langlest F, Mallet L, De Pieri M, Sentissi O, Thorens G et al. Psilocybin-assisted therapy for depression: A systematic review and dose-response meta-analysis of human studies. Eur Neuropsychopharmacol 2023; 76: 61\u201376.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"1","key":"ref45","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41398-024-02796-0","article-title":"The endogenous opioid system in the medial prefrontal cortex mediates ketamine\u2019s antidepressant-like actions","volume":"14","author":"Jiang C","year":"2024","unstructured":"Jiang C, DiLeone RJ, Pittenger C, Duman RS. The endogenous opioid system in the medial prefrontal cortex mediates ketamine\u2019s antidepressant-like actions. Transl Psychiatry 2024; 14(1): 90.","journal-title":"Transl Psychiatry"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"723064","DOI":"10.3389\/fnins.2021.723064","article-title":"Enhancement of oxytocin in the medial prefrontal cortex reverses behavioral deficits induced by repeated ketamine administration in mice","volume":"15","author":"Zhu W","year":"2021","unstructured":"Zhu W, Ding Z, Zhang Z, Wu X, Liu X, Zhang Y et al. Enhancement of oxytocin in the medial prefrontal cortex reverses behavioral deficits induced by repeated ketamine administration in mice. Front Neurosci 2021; 15: 723064.","journal-title":"Front Neurosci"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"172856","DOI":"10.1016\/j.pbb.2020.172856","article-title":"Electrophysiological biomarkers of antidepressant response to ketamine in treatment-resistant depression: Gamma power and long-term potentiation","volume":"189","author":"Gilbert JR","year":"2020","unstructured":"Gilbert JR, Zarate CA, Jr. Electrophysiological biomarkers of antidepressant response to ketamine in treatment-resistant depression: Gamma power and long-term potentiation. Pharmacol Biochem Behav 2020; 189: 172856.","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"ref48","doi-asserted-by":"crossref","first-page":"15788","DOI":"10.1038\/s41598-017-16183-x","article-title":"Ketamine\u2019s antidepressant effect is mediated by energy metabolism and antioxidant defense system","volume":"7","author":"Weckmann K","year":"2017","unstructured":"Weckmann K, Deery MJ, Howard JA, Feret R, Asara JM, Dethloff F et al. Ketamine\u2019s antidepressant effect is mediated by energy metabolism and antioxidant defense system. Sci Rep 2017; 7(1): 15788.","journal-title":"Sci Rep"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/bs.apha.2020.04.005","article-title":"The role of eEF2 kinase in the rapid antidepressant actions of ketamine","volume":"89","author":"Suzuki K","year":"2020","unstructured":"Suzuki K, Monteggia LM. The role of eEF2 kinase in the rapid antidepressant actions of ketamine. Adv Pharmacol 2020; 89: 79\u201399.","journal-title":"Adv Pharmacol"},{"issue":"7845","key":"ref50","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41586-020-03047-0","article-title":"Antidepressant actions of ketamine engage cell-specific translation via eIF4E","volume":"590","author":"Aguilar-Valles A","year":"2021","unstructured":"Aguilar-Valles A, De Gregorio D, Matta-Camacho E, Eslamizade MJ, Khlaifia A, Skaleka A et al. Antidepressant actions of ketamine engage cell-specific translation via eIF4E. Nature 2021; 590(7845): 315\u2013319.","journal-title":"Nature"},{"issue":"12","key":"ref51","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1038\/s41380-019-0400-x","article-title":"Neurobiology of rapid acting antidepressants: convergent effects on GluA1-synaptic function","volume":"24","author":"Duman RS","year":"2019","unstructured":"Duman RS, Shinohara R, Foga\u00e7a MV, Hare B. Neurobiology of rapid acting antidepressants: convergent effects on GluA1-synaptic function. Mol Psychiatry 2019; 24(12): 1816\u20131832.","journal-title":"Mol Psychiatry"},{"issue":"2","key":"ref52","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.stemcr.2015.12.009","article-title":"Genetic variability overrides the impact of parental cell type and determines iPSC dfferentiation potential","volume":"6","author":"Kytt\u00e4l\u00e4 A","year":"2016","unstructured":"Kytt\u00e4l\u00e4 A, Moraghebi R, Valensisi C, Kettunen J, Andrus C, Pasumarthy KK et al. Genetic variability overrides the impact of parental cell type and determines iPSC dfferentiation potential. Stem Cell Reports 2016; 6(2): 200\u2013212.","journal-title":"Stem Cell Reports"},{"issue":"1","key":"ref53","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3181\/00379727-106-26228","article-title":"Dephosphorylation of psilocybin to psilocin by alkaline phosphatase","volume":"106","author":"Horita A","year":"1961","unstructured":"Horita A, Weber LJ. Dephosphorylation of psilocybin to psilocin by alkaline phosphatase. Proc Soc Exp Biol Med 1961; 106(1): 32\u201334.","journal-title":"Proc Soc Exp Biol Med"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1585367","DOI":"10.3389\/fnsys.2025.1585367","article-title":"Neurobiology of psilocybin: a comprehensive overview and comparative analysis of experimental models","volume":"19","author":"Adeyinka D","year":"2025","unstructured":"Adeyinka D, Forsyth D, Currie S, Faraone N. Neurobiology of psilocybin: a comprehensive overview and comparative analysis of experimental models. Front Syst Neurosci 2025; 19: 1585367.","journal-title":"Front Syst Neurosci"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-8733841\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-8733841\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T07:07:04Z","timestamp":1784876824000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-8733841\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":54,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-8733841\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1038\/s41380-026-03768-0","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2026,2,12]]},"subtype":"preprint"}}